PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C‐Myc Feedback Loop
ABSTRACT The oncogenic role and underlying mechanism of PRMT5 in pancreatic ductal adenocarcinoma (PAAD) remained to be elucidated. In this study, we aimed to investigate the oncogenic role, underlying molecular mechanisms, and potential therapeutic value of PRMT5 in PAAD. PRMT5 was significantly up...
Saved in:
| Main Authors: | Fan Yang, Ping Song, Zhaofeng Xiao, Renyi Su, Xin Fang, Yichao Wu, Xiao Xu, Kai Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | MedComm |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mco2.70150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer
by: Carolin Schneider, et al.
Published: (2025-05-01) -
PRMT1 promotes immune escape in hepatocellular carcinoma by regulating arginine methylation modification of MYC protein
by: Han Zhou, et al.
Published: (2025-12-01) -
PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer
by: Xiaolong Wei, et al.
Published: (2025-06-01) -
Circ-PRMT5 promotes gastric cancer progression by sponging miR-145 and miR-1304 to upregulate MYC
by: Wenbo Du, et al.
Published: (2019-12-01) -
TBL2 Promotes Tumorigenesis via PRMT5/WDR77‐Mediated AKT Activation in Breast Cancer
by: Xiuqing Lu, et al.
Published: (2024-12-01)